Hard to be optimistic about EU prospects: expert

YEREVAN, February 10. /ARKA/. Andrei Ryabov, a leading researcher at the Institute of World Economy and International Relations, chief editor of “World Economy and International Relations’ magazine of the Russian Academy of Sciences and an expert for the Gorbachev Foundation and the Moscow Carnegie Fund, believes that it is difficult to be optimistic about the EU’s prospects.

“I would like to be optimistic, but so far it is impossible. It is clear that EU will need to build closer integration within itself and head towards what could be called as the United States of Europe in order to exit strong from the current crisis and become strong enough to compete not only with the United States, China and Japan, but also with members of ASEAN, Brazil and India,’ he said during an online interview in response to a question from ARKA news agency.

Andrei Ryabov’s interview was part of South Caucasus Security and NATO project which interviews leading experts and political leaders from different countries for Armenian, Azerbaijan, and Georgian media. This is the project of ‘Region’ Armenian center backed by NATO’s Public Diplomacy Department.

According to Ryabov, the Europeans do not have either the will or the leaders who can implement these ambitious goals.

“The second problem is that Europeans should abandon the relaxed lifestyle and part of social security benefits, otherwise it would be difficult to compete with China and ASEAN. It seems that the Europeans are not ready for this challenge either,” he said. -0-

spot_img

POPULAR

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

“Solis” CJSC’s bonds listed on Armenia Stock Exchange

YEREVAN, August 18. /ARKA/. The range of companies listed on the Armenia Stock Exchange (AMX) continues to expand, contributing to the development of the capital market and creating new opportunities for businesses.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

LATEST NEWS

spot_imgspot_imgspot_img